The Sirt1/Nrf2 pathway is a key factor for drug therapy in chemotherapy-induced cardiotoxicity: a Mini-Review

Med Oncol. 2024 Sep 11;41(10):244. doi: 10.1007/s12032-024-02494-3.

Abstract

The likelihood of survival for cancer patients has greatly improved due to chemotherapy medicines. However, these antitumor agents might also have unfavorable effects on the cardiovascular system, which could result in sudden or gradual cardiac failure. The production of free radicals that result in oxidative stress appears to be the key mechanism by which chemotherapy-induced cardiotoxicity (CIC) happens. Reports suggest that the Sirtuin-1 (Sirt1)/Nuclear factor E2-associated factor 2 (Nrf2) signaling pathway has been considered an alternative path for counteracting cardiotoxicity by suppressing oxidative stress, inflammation, and apoptosis. This review concludes recent knowledge about CIC with a special focus on the anti-oxidative regulation properties of the Sirt1/Nrf2 pathway.

Keywords: Cardiotoxicity; Chemotherapy; Oxidative stress; Sirt1/Nrf2 pathway.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents* / adverse effects
  • Cardiotoxicity* / etiology
  • Humans
  • NF-E2-Related Factor 2* / metabolism
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Oxidative Stress / drug effects
  • Signal Transduction* / drug effects
  • Sirtuin 1* / metabolism

Substances

  • Sirtuin 1
  • NF-E2-Related Factor 2
  • Antineoplastic Agents
  • SIRT1 protein, human
  • NFE2L2 protein, human